dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Garcia‑Carbonero, Rocio |
dc.contributor.author | Simo Perdigo, Marc |
dc.contributor.author | Del Olmo García, Maria Isabel |
dc.contributor.author | Jimenez-Fonseca, Paula |
dc.contributor.author | Pubul Núñez, Virginia |
dc.contributor.author | Capdevila Castillon, Jaume |
dc.contributor.author | Grande, Enrique |
dc.contributor.author | Carmona-Bayonas, Alberto |
dc.date.accessioned | 2022-08-18T10:30:55Z |
dc.date.available | 2022-08-18T10:30:55Z |
dc.date.issued | 2022-04 |
dc.identifier.citation | Capdevila J, Grande E, García-Carbonero R, Simó M, Del Olmo-García MI, Jiménez-Fonseca P, et al. Position Statement on the Diagnosis, Treatment, and Response Evaluation to Systemic Therapies of Advanced Neuroendocrine Tumors, With a Special Focus on Radioligand Therapy. Oncologist. 2022 Apr;27(4):e328–39. |
dc.identifier.issn | 1549-490X |
dc.identifier.uri | https://hdl.handle.net/11351/8015 |
dc.description | Teràpia neoadjuvant; Teràpia amb radionúclids del receptor de pèptids; Progressió |
dc.description.sponsorship | This project was funded by Advanced Accelerator Applications, a Novartis company. |
dc.language.iso | eng |
dc.publisher | Oxford University Press |
dc.relation.ispartofseries | The Oncologist;27(4) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Tumors neuroendocrins - Radioteràpia |
dc.subject | Tumors neuroendocrins - Diagnòstic |
dc.subject | Avaluació de resultats (Assistència sanitària) |
dc.subject.mesh | Neuroendocrine Tumors |
dc.subject.mesh | /radiotherapy |
dc.subject.mesh | Treatment Outcome |
dc.title | Position Statement on the Diagnosis, Treatment, and Response Evaluation to Systemic Therapies of Advanced Neuroendocrine Tumors, With a Special Focus on Radioligand Therapy |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1093/oncolo/oyab041 |
dc.subject.decs | tumores neuroendocrinos |
dc.subject.decs | /radioterapia |
dc.subject.decs | resultado del tratamiento |
dc.relation.publishversion | https://doi.org/10.1093/oncolo/oyab041 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Capdevila J] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. IOB-Quiron-Teknon Barcelona, Barcelona, Spain. [Grande E] Department of Medical Oncology, MD Anderson Cancer Center, Madrid, Spain. [García-Carbonero R] Department of Medical Oncology, Hospital Universitario Doce de Octubre, Madrid, Spain. [Simó M] Servei de Medicina Nuclear, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Del Olmo-García MI] Department of Endocrinology, Hospital Universitario y Politécnico la Fe de Valencia, Valencia, Spain. [Jiménez-Fonseca P] Department of Medical Oncology, Hospital Universitario Central de Asturias, ISPA, Madrid, Spain. [Carmona-Bayonas A] Department of Hematology and Medical Oncology, Hospital General Universitario Morales Meseguer, University of Murcia, Murcia, Spain. [Pubul V] Department of Nuclear Medicine Department, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain |
dc.identifier.pmid | 35380724 |
dc.identifier.wos | 000768544400001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |